Basic Molipaxin Information

• INN (International Nonproprietary Name): Trazodone
• Brand Names Available In United Kingdom: Trazodone (often sold by INN); Tablets: 50 mg, 100 mg, 150 mg, 300 mg; Capsules; Oral liquid
• ATC Code: N06AX05
• Forms & Dosages: Tablets 50 mg, 100 mg, 150 mg, 300 mg; Oral solution 10 mg/mL (varies by market); Capsules 50 mg, 100 mg (limited markets)
• Manufacturers In United Kingdom: Pfizer (original developer, U.S.); Angelini Pharma (Europe, notably for “Trittico”); Generic manufacturers include Teva, Sandoz, Mylan, Torrent, Sun Pharma, KRKA
• Registration Status In United Kingdom: Sold in the UK commonly by INN; prescription-only
• OTC / Rx Classification: Prescription-only globally; never OTC

Latest Research Highlights (UK + EU)

Worried About How Recent Studies Affect Safety And Sleep Benefits?

Recent UK and EU research from 2022–2025 has focused on trazodone’s role where depression and insomnia overlap, dose‑dependent sedation, and cardiac safety in older adults.

Regulatory reviews including MHRA and EU national agencies have highlighted orthostatic hypotension and a small absolute arrhythmia risk in vulnerable groups.

Systematic reviews and NHS audit data show that low bedtime doses often give rapid sleep‑onset benefits while full antidepressant action at standard regimens develops over weeks.

The INN is trazodone with ATC N06AX05 and common tablet strengths of 50–300 mg.

Typical antidepressant starting dose is 150 mg/day, with off‑label insomnia doses usually 25–100 mg at bedtime.

MHRA Yellow Card reports emphasise sedation and hypotension as common safety signals, and clinicians in the UK now monitor older adults more closely for falls and syncope when prescribing trazodone.

Clinical Effectiveness In The UK

Are Patients Actually Sleeping Better And Feeling Better On Trazodone?

NHS outcome data and UK primary‑care audits indicate trazodone is effective when insomnia coexists with depressive symptoms or where SSRIs are poorly tolerated.

In practice, clinicians often use lower evening doses to improve sleep continuity and divide doses when targeting antidepressant effect.

Antidepressant response is typically noted over 2–6 weeks, while sleep benefits can be reported within nights to a week.

Real‑world NHS registries report patient‑rated sleep improvement and variable depression remission rates; continuation depends largely on tolerability such as sedation, dry mouth and orthostatic symptoms.

• Measurable Outcomes: sleep latency reduction, patient sleep‑quality scores, mood scales showing gradual improvement
• Tolerability Issues: morning grogginess, dizziness, dry mouth, orthostatic hypotension
• Monitoring Steps: early review for side effects, medication reconciliation for interacting drugs

GPs and community pharmacists typically arrange an initial review within 1–2 weeks to check blood pressure and daytime function, especially when molipaxin (trazodone) is started in older adults.

Indications And Expanded Uses

Wondering What Trazodone Is Licensed For Versus How It’s Used?

MHRA and EU product labels list trazodone primarily for major depressive disorder, with some EU member states recognising sleep‑related indications per their national dossiers.

In the UK trazodone is prescription‑only and common NHS practice includes off‑label short‑term use for insomnia at 25–100 mg at bedtime when sleep hygiene and CBT‑I are inadequate.

Private clinics may use it for anxiety‑related insomnia or as adjunctive therapy for SSRI‑resistant depression, with documentation and consent required.

• MHRA‑Approved: Depression (primary)
• NHS Common: Depression plus insomnia; adjunctive sleep aid alongside antidepressant regimens
• Off‑Label: Primary insomnia (short term), anxious insomnia, adjunctive low‑dose hypnotic use
• Legal/Regulatory Notes: Off‑label prescribing should follow clinician judgement, local formularies and NICE guidance; informed consent is advised

Composition And Brand Landscape

Curious Which Brands And Formats You Might See On A UK Prescription?

The active substance is trazodone hydrochloride (INN) and in the UK most supplies are dispensed by INN with generics widely available.

Common packaging formats in the UK include tablets 50, 100, 150 and 300 mg, capsules and oral liquids supplied in blisters or bottles.

Pfizer developed the original product; Angelini markets Trittico in parts of Europe and multiple generic manufacturers such as Teva and Sandoz supply the UK market.

Generic market share in UK community pharmacies keeps costs lower for NHS dispensing and for private purchase.

Contraindications And Special Precautions

Worried About Whether Trazodone Is Safe For You Or A Relative?

Absolute contraindications include known hypersensitivity to trazodone and concurrent or recent MAOI use within 14 days.

Caution is required in people with cardiac disease, significant hepatic or renal impairment, epilepsy, and those at risk of angle‑closure glaucoma.

Pregnancy and breastfeeding require a careful risk–benefit discussion and trazodone is not recommended in paediatrics as safety has not been established.

• Cardiac History: consider ECG and specialist input for arrhythmias or heart block
• Elderly: start at lower doses and titrate slowly to reduce sedation and orthostatic hypotension
• Lifestyle: avoid driving or operating machinery until tolerability is known; avoid alcohol
• Medication Reconciliation: check for MAOIs and strong CYP3A4 inhibitors

MHRA Yellow Card trends advise extra vigilance for falls in care‑home residents when trazodone is prescribed for sleep.

Dosage Guidelines

Not Sure What Dose Suits Sleep Versus Depression?

Standard adult antidepressant dosing commonly starts at 150 mg/day in divided doses and may be titrated up, with a typical outpatient upper limit around 400 mg/day and inpatient doses up to 600 mg/day.

For insomnia, off‑label bedtime doses usually range from 25–100 mg and typically do not exceed 150 mg.

Elderly patients should start lower and titrate slowly, while hepatic or renal impairment usually requires dose reduction and close monitoring.

Tapering is recommended on discontinuation to reduce withdrawal; pharmacy counselling should specify timing and expectations for sleep vs mood effects.

Interactions Overview

Worried About Mixing Trazodone With Other Medicines?

Trazodone has important interactions with MAO inhibitors (absolute contraindication), strong CYP3A4 inhibitors or inducers, and other serotonergic agents which raise the risk of serotonin syndrome.

Pharmacists should check macrolide antibiotics, azole antifungals, some antiretrovirals and herbal supplements such as St John’s wort before dispensing trazodone.

Alcohol and other sedatives potentiate central nervous system depression and increase the risk of dangerous drowsiness.

• Avoid MAOI within 14 days of trazodone
• Review CYP3A4 inhibitors for dose adjustments or alternatives
• Monitor carefully when combining with SSRIs/SNRIs or triptans
• Counsel on alcohol avoidance and driving restrictions until tolerability is established

MHRA Yellow Card reports commonly flag sedation and orthostatic hypotension when trazodone is used with antihypertensives or opioids.

Cultural Perceptions And Patient Habits

What Patients Commonly Ask About Trazodone On UK Forums?

On Patient.info, Mumsnet and condition‑specific forums, common themes are appreciation for sleep improvement, frustration over daytime sedation, and a preference for generics to keep costs down.

There is high trust in pharmacist advice, and many patients consult NHS 111 or GP e‑consults before requesting prescriptions.

Electronic prescriptions and the NHS App help patients share medication summaries and support pharmacy medication reviews.

• Sleep Benefit Versus Daytime Somnolence Trade‑Off
• High Reliance On Pharmacist Advice In Boots, Lloyds And Independent Chemists
• Cost Sensitivity: NHS Prescription Versus Private Purchase

When molipaxin (trazodone) is started, community pharmacists commonly provide adherence support and side‑effect counselling in the first one to two weeks.

Availability And Pricing Patterns

How Easy Is It To Get Trazodone In The UK, And What Will It Cost?

Trazodone is prescription‑only across the UK and is commonly stocked by Boots, LloydsPharmacy, Superdrug and independent pharmacies, with growing availability via regulated online pharmacies and electronic prescribing.

Generics keep private purchase prices low, while NHS prescription charges vary between UK nations and affect patient choices.

Pack formats are typically 10–30 tablets and liquid forms are available for patients with swallowing difficulties.

In our online pharmacy, molipaxin is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Comparable Medicines And Preferences

Trying To Decide Between Trazodone And Other Options?

NHS prescribers commonly consider SSRIs such as sertraline or citalopram for primary depression, and mirtazapine when sedation is helpful and sexual side effects are a concern.

Amitriptyline may be chosen for severe insomnia or neuropathic pain but comes with more anticholinergic burden and falls risk in older people.

Choice depends on comorbidities, interaction risk, side‑effect profile and patient preference; pharmacists play a key role discussing sleep versus antidepressant potency and expected onset.

Frequently Asked Questions

Have Quick Questions About Taking Trazodone?

Will trazodone make me sleepy all day?

Many patients experience sedation, especially during the first days to weeks; bedtime dosing and dose adjustments can reduce daytime somnolence.

Is trazodone safe with my blood pressure tablets?

Trazodone can cause orthostatic hypotension and may interact with antihypertensives; your GP or pharmacist should check interactions and monitor blood pressure.

Can I drink alcohol?

Alcohol increases sedation risk and should be avoided until you know how trazodone affects you.

How long before I feel better?

Sleep benefits may be rapid but full antidepressant effect typically takes 4–6 weeks.

• Report suicidal thoughts immediately via GP or NHS 111.
• Seek urgent care for fainting, severe chest pain, palpitations or signs of serotonin syndrome (fever, agitation, twitching).

Guidelines For Proper Use

Want A Clear Checklist For Pharmacist Counselling And Patient Support?

Pharmacists should confirm indication and consent, explain expected onset for sleep versus mood, and review contraindications such as MAOIs and cardiac disease.

Check current medicines for CYP3A4 inhibitors and other serotonergic agents, advise on alcohol and driving, and set an early review at 1–2 weeks.

Use written patient information and NHS.uk or MHRA links to support counselling and record the interaction in the pharmacy PMR or NHS e‑prescription notes.

1. Indication and Consent: confirm reason for prescription and discuss off‑label use if applicable.
2. Baseline Checks: blood pressure, cardiac history, and full medication list.
3. Counselling: expected side effects, driving safety, alcohol avoidance.
4. Review Plan: arrange GP or pharmacist follow‑up and agree tapering strategy before stopping.

Refer complex cases to a GP, psychiatrist or local medicines management team as needed.

Delivery Across United Kingdom